从国内外指南探析速效胰岛素类似物:胰岛素泵优化应用之选  

Selection of Fast Insulin Analogues in Insulin Pump Therapy Based on Guidelines

作　　者：赵维纲 ZHAO Wei-gang(Department of Endocrinology,Key Laboratory of Endocrinology,Ministry of Health,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100730,China)

机构地区：[1]中国医学科学院北京协和医学院北京协和医院内分泌科与国家卫生健康委员会重点实验室,北京100730

出　　处：《药品评价》2020年第9期1-3,29,共4页Drug Evaluation

摘　　要：持续皮下胰岛素输注(CSII),即胰岛素泵,在我国糖尿病治疗中的应用不断增加。本文简要回顾了近期中外胰岛素泵治疗指南,重点分析胰岛素泵治疗中常见不良反应的原因和解决方案,强调通过优先选择理化稳定性较高的胰岛素制剂,可能达到减少胰岛素泵治疗中的不良反应和改善治疗效果的作用。The use of continuous subcutaneous insulin infusionin Chinese diabetic patients is constantly increasing.This paper briefly reviewed the comprehensive guidance to continuous subcutaneous insulin infusion treatment in recent Chinese and foreign guidelines for insulin pump treatment,focusing on the analysis of the causes and solutions of common adverse reactions in insulin pump treatment,then emphasized the potential of preferentially selecting insulin preparations with higher chemical and physical stability to reduce the adverse effects and improve the efficacy of continuous subcutaneous insulin infusion.

关 键 词：速效胰岛素类似物 胰岛素泵 堵管 

分 类 号：R587.1[医药卫生—内分泌]